Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cancer. 2019 Apr 12;125(15):2621–2630. doi: 10.1002/cncr.32129

Figure 1.

Figure 1.

Prevalence of HCV and HBV infection among hepatocellular carcinoma cases in SEER-Medicare, 2001–2013 by A) sex, B) age and C) race/ethnicity. Black bars indicate the fraction of cases with HCV, gray bars indicate the fraction of cases with HBV and checkered bar indicate the fraction of cases with HCV/HBV coinfection.